Form D · Other Technology
Health Gorilla, Inc.
Palo Alto, CA · CIK 0001641575
Offering snapshot reported Mar 8, 2022 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2022 | Initial | $49,999,997 | No comparison | 10 | SEC filing |
| Jun 22, 2018 | Initial | $6,338,455 | No comparison | 7 | SEC filing |
| May 7, 2015 | Initial | $2,405,915 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436227
Source: Form D, filed Mar 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jitin Asnaani | Director |
| Ilya Balandin | Director |
| Scott Barclay | Director |
| Matthew Perlman | Director |
| Chris Scoggins | Director |
| Sergio Wagner | Director |
| Steven Yaskin | Director, Executive |
| Andrei Zudin | Director, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
228 Hamilton Avenue Suite 101
Palo Alto, CA, 94301
Palo Alto, CA, 94301